Community/Retail

Bariatric vitamins ensure nutrient absorption for optimal recovery and health post surgery.

Higher levels of cyclic adenosine monophosphate (cAMP) may be key to diagnosing asthma and its severity as well as monitoring patients.

The ratio of high-density lipoprotein cholesterol (HDL-C) to low-density lipoprotein cholesterol (LDL-C) can predict cardiovascular disease (CVD) risk in patients with and without diabetes.

CDC layoffs threaten public health surveillance, prompting urgent reinstatement of staff as pharmacists face challenges in community health response.

Each month, Timothy Ulbrich will share lessons on mindset, strategy, and habits to help pharmacists achieve lasting security and financial freedom.

Compared with lower-valent vaccines and PPSV23, higher-valent pneumococcal conjugate vaccines were more cost-effective, especially in high-income countries.

Inhaled insulin Afrezza offers a rapid-acting alternative for children with type 1 diabetes, enhancing blood glucose control and patient satisfaction.

FDA approves Uzedy, an extended-release injectable formulation of risperidone, enhancing treatment options for adults with bipolar I disorder.

The pharmaceutical giant will reportedly lower its drug prices to align with most-favored-nation status.

A hybrid chatbot that evaluates stages of change in pneumococcal vaccination desires while providing artificial intelligence (AI)-based Q&A opportunities improved uptake in older adults.

The FDA approves Eydenzelt, a biosimilar for retinal diseases, enhancing treatment options for diabetic macular edema and age-related macular degeneration.

Researchers highlight the critical link between school vaccination rates and measles outbreaks, urging targeted public health strategies to combat misinformation and improve MMR coverage.

Discover groundbreaking FDA approvals for innovative treatments, including semaglutide for liver health and bumetanide nasal spray for heart failure.

Explore recent FDA-approved drugs from September 2025.

Ron Lanton advises pharmacies to maintain compliance, explore contingency options, and stay engaged with policymakers during the government shutdown.

Research reveals that poor glycemic control in adolescents with type 1 diabetes significantly increases the risk of developing neuropathy in adulthood.

Tramadol provides only limited pain relief while carrying a significant risk of serious adverse effects.

Discover how supplements support women's health during menopause, enhancing well-being and easing symptoms effectively.

GLP-1 receptor agonists significantly influence FDG-PET-CT scan interpretations, potentially leading to misdiagnosis in cancer detection.

Many factors lead to policy change and market viability, but none more than perceived need and desire to receive a service.

As one of the most prescribed medications worldwide, proton pump inhibitor use could serve as a bulwark against severe outcomes in hospitalized adults with COVID-19.

Pharmaceutical companies navigate FDA regulations and explore AI solutions to enhance compliance in drug advertising and enforcement.

Researchers explore continuous glucose monitors (CGMs) for early detection of insulin issues, aiming to prevent diabetes progression and improve screening methods.

New research confirms that calcium supplements do not increase dementia risk in older women, supporting their use for bone health without cognitive concerns.

Christian Ruff, MD, highlights pharmacists as essential clinical partners who help optimize drug selection, dosing, and safety for patients with complex needs.

Cagrilintide shows significant weight loss in adults with obesity, marking a breakthrough in obesity treatment with promising phase 3 trial results.

Pharmacists’ accessibility and expertise make them essential allies for patients managing weight through medication, Donna Ryan explains.